Payne Capital’s Merck MRK Stock Holding History

Payne Capital’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.37M	Hold	10,637	–	–	1.14%	26
2026 Q1	$1.28M	Hold	10,637	–	–	1.17%	26
2025 Q4	$1.12M	Buy	10,637 +97	+0.9%	+$9.11K	1.14%	24
2025 Q3	$885K	Buy	+10,540	New	+$868K	0.9%	29

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Payne Capital's MRK Position: Q2 2026 in Review

Payne Capital held its Merck (MRK) position steady in Q2 2026 at 10,637 shares worth $1.37M. The position accounts for 1.14% of the portfolio, ranked #26.

Payne Capital first reported a position in MRK in Q3 2025 and has held it in 4 quarters since. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Payne Capital held 10,637 shares of Merck worth $1.37M as of Q2 2026.
Payne Capital left its Merck share count unchanged in Q2 2026.
Merck made up 1.14% of Payne Capital's portfolio in Q2 2026, its #26 holding.
Payne Capital first reported a position in Merck in Q3 2025 and has held it in 4 quarters since.
3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Payne Capital's 13F filing for Q2 2026, filed 11 Aug 2026.